These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 15975534

  • 1. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 2. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T.
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [Abstract] [Full Text] [Related]

  • 3. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C.
    Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, Inoue K, Watanabe K, Otsu S, Fujioka T.
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [Abstract] [Full Text] [Related]

  • 5. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ, Boer WA, Geldof H, Hazelhoff B, Bergmans P, Tytgat GN, Smout AJ.
    Aliment Pharmacol Ther; 2004 Aug 15; 20(4):451-8. PubMed ID: 15298640
    [Abstract] [Full Text] [Related]

  • 6. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K, Adachi K, Komazawa Y, Mihara T, Miki M, Azumi T, Fujisawa T, Katsube T, Kinoshita Y.
    J Gastroenterol Hepatol; 2006 Oct 15; 21(10):1581-5. PubMed ID: 16928220
    [Abstract] [Full Text] [Related]

  • 7. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 15; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 8. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Dec 15; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 9. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B, McColl K.
    Aliment Pharmacol Ther; 2005 Aug 15; 22 Suppl 1():32-40. PubMed ID: 16042657
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A, Azuma T, Okajima T, Ohtani M, Dojo M, Yamazaki Y, Kuriyama M.
    Aliment Pharmacol Ther; 2004 Jul 15; 20 Suppl 1():102-6. PubMed ID: 15298614
    [Abstract] [Full Text] [Related]

  • 11. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J, Fullerton H, Briseno M, Cui H, Fass R.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1123-30. PubMed ID: 15142202
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, Oshima T, Togawa S, Kubota E, Yamada T, Mori Y, Fujita F, Ohara H, Nakao H, Sobue S, Joh T, Itoh M.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():2-9. PubMed ID: 15943840
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov 15; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun 15; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 15. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC, Chen JJ, Hu TH, Lu SN, Changchien CS.
    Hepatogastroenterology; 2005 Jun 15; 52(65):1617-21. PubMed ID: 16201128
    [Abstract] [Full Text] [Related]

  • 16. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 17. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA.
    Ital J Gastroenterol Hepatol; 1997 Dec 15; 29(6):569-73. PubMed ID: 9513835
    [Abstract] [Full Text] [Related]

  • 18. Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
    Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, Kodama M, Kagawa J.
    J Gastroenterol; 2003 Dec 15; 38(10):937-41. PubMed ID: 14614600
    [Abstract] [Full Text] [Related]

  • 19. Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.
    Bergman MP, Klinkenberg-Knol EC, Faller G, Aar A, Lakhai W, Vandenbroucke-Grauls CM, Kuipers EJ, Appelmelk BJ.
    Aliment Pharmacol Ther; 2005 Apr 15; 21(8):977-83. PubMed ID: 15813833
    [Abstract] [Full Text] [Related]

  • 20. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Kanayama S.
    Nihon Rinsho; 1999 Jan 15; 57(1):153-6. PubMed ID: 10036954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.